Alphamab Oncology (HKG:9966)
Hong Kong
· Delayed Price · Currency is HKD 8.68
+0.67 (8.36%)
Mar 10, 2026, 3:59 PM HKT
Alphamab Oncology Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 7,758 | 3,368 | 6,407 | 10,149 | 12,743 | 15,221 | Upgrade
|
| Market Cap Growth | 115.55% | -47.42% | -36.88% | -20.36% | -16.28% | 21.20% | Upgrade
|
| Enterprise Value | 6,256 | 2,154 | 5,004 | 8,763 | 10,814 | 12,776 | Upgrade
|
| Last Close Price | 8.01 | 3.50 | 6.64 | 10.80 | 13.60 | 16.28 | Upgrade
|
| PE Ratio | 30.94 | 19.03 | - | - | - | - | Upgrade
|
| PS Ratio | 9.01 | 4.95 | 26.58 | 53.81 | 71.10 | - | Upgrade
|
| PB Ratio | 3.82 | 1.73 | 3.48 | 5.76 | 5.55 | 5.64 | Upgrade
|
| P/TBV Ratio | 3.82 | 1.73 | 3.48 | 5.76 | 5.55 | 5.64 | Upgrade
|
| P/FCF Ratio | 32.54 | 16.61 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 27.60 | 14.91 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 7.26 | 3.16 | 20.76 | 46.46 | 60.34 | - | Upgrade
|
| EV/EBITDA Ratio | 22.00 | 12.24 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 30.36 | 20.04 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 26.23 | 10.62 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.10 | 0.15 | 0.22 | 0.34 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 1.05 | 1.04 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | 1.26 | 0.98 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.74 | -0.76 | -0.69 | -0.64 | -0.72 | -0.81 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.45 | -8.38 | 4.30 | 2.57 | 3.48 | 4.72 | Upgrade
|
| Net Debt / FCF Ratio | -6.30 | -7.27 | 4.81 | 2.34 | 2.82 | 4.20 | Upgrade
|
| Asset Turnover | 0.35 | 0.29 | 0.10 | 0.07 | 0.06 | - | Upgrade
|
| Inventory Turnover | 0.83 | 0.75 | 0.77 | 0.72 | 0.06 | - | Upgrade
|
| Quick Ratio | 4.76 | 6.41 | 5.55 | 3.72 | 3.22 | 6.52 | Upgrade
|
| Current Ratio | 4.98 | 6.74 | 5.84 | 3.88 | 3.32 | 6.67 | Upgrade
|
| Return on Equity (ROE) | 13.37% | 9.49% | -13.04% | -19.00% | -19.91% | -18.21% | Upgrade
|
| Return on Assets (ROA) | 5.22% | 2.88% | -9.50% | -11.21% | -9.72% | -9.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.40% | 5.10% | -17.30% | -25.00% | -20.10% | -17.70% | Upgrade
|
| Earnings Yield | 3.29% | 5.25% | -3.62% | -3.63% | -3.97% | -3.34% | Upgrade
|
| FCF Yield | 3.07% | 6.02% | -4.11% | -4.79% | -4.61% | -3.42% | Upgrade
|
| Buyback Yield / Dilution | -3.37% | -2.53% | -2.50% | -0.11% | -0.62% | -73.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.